| You are receiving this Industry-Sponsored email because you are registered for 2025 ATMRD Congress. |
|
| IN PURSUIT OF THE IMPOSSIBLE |
|
|
Mitsubishi Tanabe Pharma America, Inc. (MTPA) is relentlessly focused on the goal of
providing therapies for some of the most difficult-to-treat diseases. Our
teams work diligently to develop science-based options that will
enable healthcare providers to offer proven treatments for devastating illnesses.
We thrive on navigating complex problems in science and medicine and strive to support
patients who live with debilitating diseases.
|
|
| WHILE ATTENDING ATMRD, PLEASE VISIT OUR BOOTH TO |
| LEARN MORE ABOUT MTPA. |
|
|
|
PMD Alliance has provided space for this non-CME ancillary event. The program was
independently produced, was not subject to review by PMD Alliance, and is not part of
the scientific/educational program offered by PMD Alliance.
|
|
© 2025 Mitsubishi Tanabe Pharma America, Inc. All rights reserved. CP-MTPA-US-0497 06/25
|
|
FOR US HEALTHCARE PROFESSIONALS ONLY.
|
|